ArticleThe Milbank quarterly2022
Financing Approaches to Social Prescribing Programs in England and the United States.
Article in The Milbank quarterly, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Social prescribing by community nurses in southeastern Australia: a qualitative study.Journal of research in nursing : JRN · 2026Article
- A qualitative investigation of stakeholders' perceptions of social prescribing for families with infants through the lens of a creative play on prescription programme for 0-2-year-olds and their carers.Public health in practice (Oxford, England) · 2026Article
- The future of U.S. social prescribing: foundations, implementation, and leadership summit insights.Frontiers in public health · 2026Article
- Identifying key outcomes for social prescribing research in the US: a Delphi method study.Frontiers in public health · 2026Article
- Characterizing a heterogeneous chronic patient population for redesigning person-centred bundled payment models using risk-mitigating measures.The European journal of health economics : HEPAC : health economics in prevention and care · 2025Article
- The potentials of digital technology in social prescribing: a qualitative study of key stakeholders' perspectives.BMC public health · 2025Article
- Article
- Survey of general practitioners' awareness, practice and perception of social prescribing across Europe.The European journal of general practice · 2024Article
- The performance of general practice in the English National Health Service (NHS): an analysis using Starfield's framework for primary care.Health affairs scholar · 2024Article
- Stakeholder views on addressing challenges to the implementation of social prescribing in the United Kingdom.Frontiers in health services · 2024Article
- The challenges and rewards of social prescribing in family medicine.Frontiers in health services · 2024Article
- Improving health equity through health care systems research.Health services research · 2023Article
- Nature-Based Interventions in the UK: A Mixed Methods Study Exploring Green Prescribing for Promoting the Mental Wellbeing of Young Pregnant Women.International journal of environmental research and public health · 2023Article
- Pursuing a Cross-Sector Approach to Advance Child Health Equity.Pediatric clinics of North America · 2023Review
- Article
- Models of social prescribing to address non-medical needs in adults: a scoping review.BMC health services research · 2023Article
- Developing a research agenda for social prescribing in the UK using lessons from the US.The British journal of general practice : the journal of the Royal College of General Practitioners · 2022Article
- Interprofessional collaboration to support patients with social problems in general practice-a qualitative focus group study.BMC primary care · 2022Article
- Global developments in social prescribing.BMJ global health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Policy Points The number of social prescribing practices, which aim to link patients with nonmedical services and supports to address patients' social needs, is increasing in both England and the United States. Traditional health care financing mechanisms were not designed to support social prescribing practices, and flexible payment approaches may not support their widespread adoption. Policymakers in both countries are shifting toward developing explicit financing streams for social prescribing programs. Consequently, we need an evaluation of them to assess their success in supporting both the acceptance of these programs and their impacts. Investment in community-based organizations and wider public services will likely be crucial to both the long-term effectiveness and the sustainability of social prescribing.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.